Nicotinamide-based kinase inhibitors

Details Nicotinamide-based kinase inhibitors Nicotinamide-based kinase inhibitors

2003-12-15

2011-10-04

Morris, Patricia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S316000

Reexamination Certificate

active

08030336

ABSTRACT:
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.

REFERENCES:
patent: 5756524 (1998-05-01), Riordan et al.
patent: 2004/0110802 (2004-06-01), Thorarensen et al.
patent: 07-048370 (1995-02-01), None
patent: WO-95/25723 (1995-09-01), None
patent: WO-98/38167 (1998-09-01), None
patent: WO-02/44137 (2002-06-01), None
patent: WO-02/64565 (2002-08-01), None
Balant et al., “Metabolic Considerations, etc.,” in Manfred ed, Burger's Medicinal Chemistry and Drug Discovery, 5th ed. vol. 1: Principles and Practice, John Wiley & Sons, Inc., 1995.
Vippagunta et al., “Crystalline Solids”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Jain et al., “Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6), 315-329.
Guillory (in Brittain ed.), “Polymorphism, etc.,” NY: Marcel Dekker, Inc., 1999, 1-2, 183-226.
Supplementary European Search Report for EP 03767297.9, issued Sep. 18, 2007, 1 page.
Traxler, Expert Opinion on Therapeutic Patents (1998) 8(12):1599-1625.
Traxler, Expert Opinion on Therapeutic Patents (1997) 7(6):571-588.
International Search Report for PCT/AU03/001666, mailed on Feb. 18, 2004, 3 pages.
Johnson et al., J. Pharm. Sci. (1973) 62(11):1881-1883.

Affiliated with

Also associated with

Rating

Nicotinamide-based kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nicotinamide-based kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinamide-based kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4299770